市場調査レポート
商品コード
1293059

造影剤およびインジェクターシステム市場 - 世界および地域別分析:製品別・国別分析 - 分析と予測(2022年~2026年)

Contrast Media Agent and Injector System Market - A Global and Regional Analysis: Focus on Product and Country Analysis - Analysis and Forecast, 2022-2026

出版日: | 発行: BIS Research | ページ情報: 英文 183 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
造影剤およびインジェクターシステム市場 - 世界および地域別分析:製品別・国別分析 - 分析と予測(2022年~2026年)
出版日: 2023年06月12日
発行: BIS Research
ページ情報: 英文 183 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の造影剤およびインジェクターシステムの市場規模は、2022年に76億3,460万米ドルとなりました。

同市場は今後、2022年~2026年にかけて6.20%のCAGRで拡大し、2026年には97億1,230万米ドルに達すると予測されています。

当レポートでは、世界の造影剤およびインジェクターシステム市場について調査し、市場の概要とともに、製品別・国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場

  • 世界市場の展望
  • 市場概要
  • 業界の展望
  • COVID-19が造影剤およびインジェクターシステム市場に与える影響
  • 市場力学

第2章 製品

  • 概要
  • 成長シェアマトリックス
  • 造影剤
  • インジェクターシステム

第3章 地域

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第4章 市場-競合ベンチマーキングと企業プロファイル

  • 競合ベンチマーキング
  • 造影剤エコシステムにおける活躍企業
  • 企業プロファイル
    • Bayer AG
    • Beijing Beilu Pharmaceutical Co. Ltd.
    • Bracco Group
    • Fresenius SE & Co. KGaA
    • FUJIFILM Holdings Corporation
    • General Electric Company
    • Guerbet
    • Jiangsu Hengrui Pharmaceutical Co., Ltd.
    • Jodas Expoim Pvt. Ltd.
    • Lantheus Holdings, Inc.
    • Shenzen Seacrown Electromechanical Co., Ltd.
    • Sino Medical-Device Technology Co., Ltd.
    • ulrich GmbH & Co. KG
    • Unijules Life Sciences Ltd.
図表

List of Figures

  • Figure 1: Global Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 2: Global Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 3: Global Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
  • Figure 4: Global Contrast Media Agent and Injector System Market (by Region), $Million, 2021 and 2026
  • Figure 5: Global Contrast Media Agent and Injector System Market Segmentation
  • Figure 6: Global Contrast Media Agent and Injector System Market: Research Methodology
  • Figure 7: Primary Research Methodology
  • Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 9: Top-Down Approach (Segment-Wise Analysis)
  • Figure 10: Global Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
  • Figure 11: Global Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
  • Figure 12: Number of CT Scans Per One Million Inhabitants in the U.S., 2015, 2017, and 2019
  • Figure 13: Number of CT Scans Per One Million Inhabitants in Europe (by Country), 2015, 2017, and 2019
  • Figure 14: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
  • Figure 15: Number of CT Scans Per One Million Inhabitants, 2018-2020
  • Figure 16: Number of Scans by Imaging Modalities in the U.K. from 2018-2019 to 2020-2021, Million
  • Figure 17: Global Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 18: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
  • Figure 19: Global Incidence of Cardiovascular Disease, 2015 - 2019, Million
  • Figure 20: Innovative Vendors Product Solutions
  • Figure 21: Global Contrast Media Agent and Injector System Market (by Product)
  • Figure 22: Global Contrast Media Agent and Injector System Market, Incremental Opportunity, (by Product), $Million, 2022-2026
  • Figure 23: Global Contrast Media Agent and Injector System Market, Growth-Share Matrix (by Product), 2022-2026
  • Figure 24: Global Contrast Media Agent Market, $Million, 2021-2026
  • Figure 25: Global Contrast Media Agent Market (X-Ray/CT Scan), $Million, 2021-2026
  • Figure 26: Global Contrast Media Agent Market (MRI), $Million, 2021-2026
  • Figure 27: Global Contrast Media Agent Market (Ultrasound), $Million, 2021-2026
  • Figure 28: Global Contrast Media Agent Market (Iodine-Based Contrast Media Agent), $Million, 2021-2026
  • Figure 29: Global Contrast Media Agent Market (Gadolinium-Based Contrast Media Agent), $Million, 2021-2026
  • Figure 30: Global Contrast Media Agent Market (Barium-Based Contrast Media Agent), $Million, 2021-2026
  • Figure 31: Global Contrast Media Agent Market (Microbubble Contrast Media Agent), $Million, 2021-2026
  • Figure 32: Global Contrast Media Agent Market (Others), $Million, 2021-2026
  • Figure 33: Global Contrast Media Injector System Market, $Million, 2021-2026
  • Figure 34: Global Contrast Media Injector System Market (Injector), $Million, 2021-2026
  • Figure 35: Global Contrast Media Injector Systems Market (Consumables and Accessories), $Million, 2021-2026
  • Figure 36: Global Contrast Media CT Injector System Market by Product, $Million, 2021-2026
  • Figure 37: Global Contrast Media MRI Injector System Market, by Product, $Million, 2021-2026
  • Figure 38: Global Contrast Media Cardiovascular/Angiography Injector System Market, by Product, $Million, 2021-2026
  • Figure 39: Global Contrast Media Injector System Market (Single-Head Injectors), $Million, 2021-2026
  • Figure 40: Global Contrast Media Injector System Market (Dual-Head Injectors), $Million, 2021-2026
  • Figure 41: Global Contrast Media Injector System Market (Syringeless Injectors), $Million, 2021-2026
  • Figure 42: Global Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
  • Figure 43: North America Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 44: North America Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 45: North America Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 46: North America Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 47: U.S. Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 48: U.S. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 49: U.S. Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 50: Canada Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 51: Canada Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 52: Canada Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 53: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 54: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 55: Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 56: Europe Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 57: Germany Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 58: Germany Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 59: Germany Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 60: Italy Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 61: Italy Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 62: Italy Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 63: France Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 64: France Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 65: France Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 66: Number of Scans by Imaging Modalities in the U.K. from 2015-2016 to 2020-2021, Million
  • Figure 67: U.K. Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 68: U.K. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 69: U.K. Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 70: Number of CT Scanners in Spain per One Million Inhabitants, 2014-2020
  • Figure 71: Spain Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 72: Spain Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 73: Spain Contrast Media and Injector System Market (by Product), $Million, 2021-2026
  • Figure 74: Rest-of-Europe Contrast Media Agent and Injector System Market, $Million, 2022-2026
  • Figure 75: Rest-of-Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 76: Rest-of-Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 77: Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 78: Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 79: Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 80: Asia-Pacific Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 81: China Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 82: China Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 83: China Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 84: Japan Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 85: Japan Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 86: Japan Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 87: India Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 88: India Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 89: India Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 90: Australia Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 91: Australia Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 92: Australia Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 93: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 94: Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 95: Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 96: Rest-of-the-World Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 97: Rest-of-the-World Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 98: Rest-of-the-World Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 99: Global Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
  • Figure 100: Regulatory and Legal Activities, January 2018-May 2023
  • Figure 101: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
  • Figure 102: Mergers and Acquisitions, January 2018-May 2023
  • Figure 103: New Offerings, January 2018-May 2023
  • Figure 104: Global Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 105: Global Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 106: Bayer AG: Product Portfolio
  • Figure 107: Bayer AG: Overall Financials, $Million, 2020-2022
  • Figure 108: Bayer AG: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 109: Bayer AG: Net Revenue (by Region), $Million, 2020-2022
  • Figure 110: Bayer AG: R&D Expenditure, $Million, 2020-2022
  • Figure 111: Beijing Beilu Pharmaceutical Co. Ltd.: Product Portfolio
  • Figure 112: Bracco Group: Product Portfolio
  • Figure 113: Fresenius SE & Co. KGaA: Product Portfolio
  • Figure 114: Fresenius SE & Co. KGaA: Overall Financials, $Million, 2020-2022
  • Figure 115: Fresenius SE & Co. KGaA: Net Revenue (by Region), $Million, 2020-2022
  • Figure 116: Fresenius SE & Co. KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 117: FUJIFILM Holdings Corporation: Overall Product Portfolio
  • Figure 118: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2020-2022
  • Figure 119: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 120: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2020-2022
  • Figure 121: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2020-2022
  • Figure 122: General Electric Company: Product Portfolio
  • Figure 123: General Electric Company: Overall Financials, $Million, 2020-2022
  • Figure 124: General Electric Company: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 125: General Electric Company: Net Revenue (by Region), $Million, 2020-2022
  • Figure 126: General Electric Company: R&D Expenditure, $Million, 2020-2022
  • Figure 127: Guerbet: Product Portfolio
  • Figure 128: Guerbet: Overall Financials, $Million, 2020-2022
  • Figure 129: Guerbet: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 130: Jiangsu Hengrui Pharmaceutical Co., Ltd.: Product Portfolio
  • Figure 131: Jodas Expoim Pvt. Ltd.: Product Portfolio
  • Figure 132: Lantheus Holdings, Inc.: Product Portfolio
  • Figure 133: Lantheus Holdings, Inc.: Overall Financials, $Million, 2020-2022
  • Figure 134: Lantheus Holdings, Inc.: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 135: Lantheus Holdings, Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 136: Shenzen Seacrown Electromechanical Co., Ltd.: Product Portfolio
  • Figure 137: Sino Medical-Device Technology Co., Ltd.: Product Portfolio
  • Figure 138: ulrich GmbH & Co. KG: Product Portfolio
  • Figure 139: Unijules Life Sciences Ltd.: Product Portfolio

List of Tables

  • Table 1: Global Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Global Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
  • Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
  • Table 5: Some of the Contrast Media Reactions and Effects
  • Table 6: Guidelines for Contrast Administration and Hydration
  • Table 7: Contrast Media Agent Market (CT Injector Systems)
  • Table 8: North America Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 9: Europe Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 10: Asia-Pacific Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 11: Rest-of-the-World Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 12: Contrast Media Ecosystem Active Players
目次
Product Code: BHR1401SA

“Global Contrast Media Agent and Injector System Market to Reach $9,712.3 Million by 2026.”

Industry Overview

The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026. The market is driven by factors such as the increasing prevalence of cancer and cardiovascular diseases leading to an upsurge in demand for imaging with contrast media agent and injector system and image-guided diagnostics.

Market Lifecycle Stage

The global contrast media agent and injector system market is developing. The global contrast media agent and injector system market has witnessed several collaborations among the market players. The collaborations are aimed at combining capabilities, expanding the customer base, and marketing, among others.

The opportunity for growth of the global contrast media agent and injector system market lies in continued research and development activities for manufacturing innovative contrast media agent and injector system. Many pharmaceutical companies are expanding their businesses and becoming more outsourcing-oriented.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the world's healthcare sector, especially the contrast media agent and injector system sector. The COVID-19 pandemic led to the rescheduling of non-essential diagnostic tests and treatment procedures in order to allocate more resources toward the management of COVID-19. The American College of Radiology postponed non-urgent outpatient visits in accordance with the guidelines put forth by the Centers for Disease Control and Preventio (CDC). According to a paper published in the Radiological Society of North America (RSNA) in April 2020, titled 'The Economic Impact of the COVID-19 Pandemic on Radiology Practices,' imaging volumes were affected with the greatest decline observed in outpatient settings, followed by emergency departments and inpatient settings.

The future impact of COVID-19 on the demand and supply across the global contrast media agent and injector system market depends on the abilities of stakeholders to withstand unforeseeable scenarios in the future. The intensity of impact due to COVID-19 in the future will depend on the current efforts being made by companies to equip their supply chains with the necessary components and processes to remain responsive.

Market Segmentation:

Segmentation 1: by Product

  • Contrast Media Agents
  • Injector Systems

The global contrast media agent and injector system market (by product) is expected to be dominated by the contrast media agents segment.

Segmentation: Contrast Media Agents (by Modality)

  • X-Ray/CT Scan
  • MRI
  • Ultrasound

The global contrast media agent market (by modality) is expected to be dominated by the X-Ray/CT scan.

Segmentation: Contrast Media Agents (by Type of Media Agent)

  • Iodine-Based Contrast Media Agent
  • Gadolinium-Based Contrast Media Agent
  • Barium-Based Contrast Media Agent
  • Microbubble Contrast Media Agent
  • Others

The global contrast media agent market (by type of media agent) is expected to be dominated by iodine-based contrast media agent.

Segmentation: Injector Systems (by Modality)

  • CT Injector Systems
  • MRI Injector Systems
  • Cardiovascular/Angiography Injector Systems

The global contrast media injector system market (by modality) is expected to be dominated by CT injector systems.

Segmentation: Injector Systems (by Product)

  • Injector
  • Consumables and Accessories

The global contrast media injector system market (by product) is expected to be dominated by consumables and accessories.

Segmentation: Injector Systems (by Injector Type)

  • Single-Head Injectors
  • Dual-Head Injectors
  • Syringeless Injectors

The global contrast media injector system market (by injector type) is expected to be dominated by single-head injectors.

Segmentation 2: by Region

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe
  • Asia-Pacific - China, Japan, India, Australia, and Rest-of-Asia-Pacific
  • Rest-of-the-World

The global contrast media agent and injector system market (by region) is dominated by the North America region.

Recent Developments in Global Contrast Media Agent and Injector System Market

  • In January 2023, Bayer AG received approval in Europe for its Ultravist-300, -370, an iodine-based contrast agent for contrast-enhanced mammography (CEM).
  • In December 2022, Beijing Beilu Pharmaceutical Co. Ltd. expanded its business by establishing a wholly-owned subsidiary in Hong Kong.
  • In April 2022, Beijing Beilu Pharmaceutical Co., Ltd.'s gadobutrol injection received the "Drug Registration Certificate" from the National Medial Production Administration (NMPA).
  • In February 2023, Bracco Group partnered with Wellstar Health System. Through this partnership, the company conducted trials for its FDA-approved VUEWAY (gadopiclenol) injection, which is a contrast agent for use in MRI.
  • In February 2023, Bracco Group acquired all the shares of Bracco-Eisai from Eisai. Furthermore, the company also changed the name of the company from Bracco-Eisai to Bracco Japan, Ltd.
  • In July 2022, Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA, launched its range of generic contrast media agents' generics in the U.S.
  • In December 2022, General Electric Company partnered with ulrich GmbH & Co. KG. Through this partnership, the companies aimed to offer a branded multi-dose contrast media injector in the U.S.

Demand - Drivers and Limitations

The following are the drivers for the global contrast media agent and injector system market:

  • Increasing prevalence of cancer and cardiovascular diseases leading to an upsurge in demand for imaging with contrast media agent and injector system
  • Upsurge in demand for image-guided diagnostics
  • Growing number of regulatory approvals

The market is expected to face some limitations as well due to the following challenges:

  • Rising health concerns post usage of contrast media agents in the body

How can this report add value to an organization?

  • Growth/Marketing Strategy: The global contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
  • Competitive Strategy: The global contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies have the opportunity to expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled:

  • Bayer AG
  • Beijing Beilu Pharmaceutical Co. Ltd.
  • Bracco Group
  • Fresenius SE & Co. KGaA
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Guerbet
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Holdings, Inc.
  • Shenzen Seacrown Electromechanical Co., Ltd.
  • Sino Medical-Device Technology Co., Ltd.
  • ulrich GmbH & Co. KG
  • Unijules Life Sciences Ltd.

Table of Contents

1 Markets

  • 1.1 Global Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion and Exclusion Criteria
    • 1.1.3 Key Findings
  • 1.2 Market Overview
  • 1.3 Industry Outlook
    • 1.3.1 Regulatory and Legal Requirements and Framework
      • 1.3.1.1 Regulatory and Legal Requirements and Framework in the U.S.
      • 1.3.1.2 Regulatory and Legal Requirements and Framework in Europe
      • 1.3.1.3 Regulatory and Legal Requirements and Framework in Asia-Pacific
        • 1.3.1.3.1 China
        • 1.3.1.3.2 Japan
    • 1.3.2 Patent Analysis
      • 1.3.2.1 Patent Filing Trend (by Year)
      • 1.3.2.2 Patent Filing Trend (by Country)
    • 1.3.3 Key Trends
      • 1.3.3.1 Nanoparticle-Based Contrast Agents
      • 1.3.3.2 Development of Safer Contrast Media Agent
      • 1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
  • 1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
    • 1.4.1 Pre-COVID-19 Impact
    • 1.4.2 During COVID-19 Impact
    • 1.4.3 Post-COVID-19 Impact
  • 1.5 Market Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Market Drivers
      • 1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
      • 1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
      • 1.5.2.3 Growing Number of Regulatory Approvals
    • 1.5.3 Market Restraints
      • 1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
    • 1.5.4 Market Opportunities
      • 1.5.4.1 IT Advances in Contrast Media Injectors

2 Product

  • 2.1 Overview
  • 2.2 Growth-Share Matrix
  • 2.3 Contrast Media Agents
    • 2.3.1 Market Dynamics
    • 2.3.2 Market Size and Forecast
      • 2.3.2.1 By Modality
        • 2.3.2.1.1 X-Ray/CT Scan
        • 2.3.2.1.2 MRI
        • 2.3.2.1.3 Ultrasound
      • 2.3.2.2 By Type of Media Agent
        • 2.3.2.2.1 Iodine-Based Contrast Media Agent
        • 2.3.2.2.2 Gadolinium-Based Contrast Media Agent
        • 2.3.2.2.3 Barium-Based Contrast Media Agent
        • 2.3.2.2.4 Microbubble Contrast Media Agent
        • 2.3.2.2.5 Others
  • 2.4 Injector Systems
    • 2.4.1 Market Dynamics
    • 2.4.2 Market Size and Forecast
      • 2.4.2.1 By Product
        • 2.4.2.1.1 Injector
        • 2.4.2.1.2 Consumables and Accessories
      • 2.4.2.2 By Modality
        • 2.4.2.2.1 CT Injector Systems
        • 2.4.2.2.2 MRI Injector Systems
        • 2.4.2.2.3 Cardiovascular/Angiography Injector Systems
      • 2.4.2.3 By Injector Type
        • 2.4.2.3.1 Single-Head Injectors
        • 2.4.2.3.2 Dual-Head Injectors
        • 2.4.2.3.3 Syringeless Injectors

3 Region

  • 3.1 Overview
  • 3.2 North America
    • 3.2.1 Key Findings
    • 3.2.2 Market Dynamics
    • 3.2.3 Impact Analysis
    • 3.2.4 Market Sizing and Forecast
      • 3.2.4.1 North America Contrast Media Agent and Injector System Market (by Product)
        • 3.2.4.1.1 North America Contrast Media Injector System Market (by Product)
      • 3.2.4.2 North America Contrast Media Agent and Injector System Market (by Country)
        • 3.2.4.2.1 U.S.
          • 3.2.4.2.1.1 Market Sizing and Forecast
          • 3.2.4.2.1.1.1 U.S. Contrast Media Agent and Injector System Market (by Product)
          • 3.2.4.2.1.1.1.1 U.S. Contrast Media Injector System Market (by Product)
        • 3.2.4.2.2 Canada
          • 3.2.4.2.2.1 Market Sizing and Forecast
          • 3.2.4.2.2.1.1 Canada Contrast Media Agent and Injector System Market (by Product)
          • 3.2.4.2.2.1.1.1 Canada Contrast Media Injector System Market (by Product)
  • 3.3 Europe
    • 3.3.1 Key Findings
    • 3.3.2 Market Dynamics
      • 3.3.2.1 Impact Analysis
    • 3.3.3 Market Size and Forecast
      • 3.3.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.1.1 Europe Contrast Media Injector System Market (by Product)
      • 3.3.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
        • 3.3.3.2.1 Germany
          • 3.3.3.2.1.1 Market Sizing and Forecast
          • 3.3.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
          • 3.3.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
        • 3.3.3.2.2 Italy
          • 3.3.3.2.2.1 Market Sizing and Forecast
          • 3.3.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
          • 3.3.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
        • 3.3.3.2.3 France
          • 3.3.3.2.3.1 Market Sizing and Forecast
          • 3.3.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
          • 3.3.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
        • 3.3.3.2.4 U.K.
          • 3.3.3.2.4.1 Market Sizing and Forecast
          • 3.3.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
          • 3.3.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
        • 3.3.3.2.5 Spain
          • 3.3.3.2.5.1 Market Sizing and Forecast
          • 3.3.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
          • 3.3.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
        • 3.3.3.2.6 Rest-of-Europe
          • 3.3.3.2.6.1 Market Sizing and Forecast
          • 3.3.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
          • 3.3.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)
  • 3.4 Asia-Pacific
    • 3.4.1 Key Findings
    • 3.4.2 Market Dynamics
      • 3.4.2.1 Impact Analysis
    • 3.4.3 Market Size and Forecast
      • 3.4.3.1 Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
        • 3.4.3.1.1 Asia-Pacific Contrast Media Injector System Market (by Product)
      • 3.4.3.2 Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
        • 3.4.3.2.1 China
          • 3.4.3.2.1.1 Market Sizing and Forecast
          • 3.4.3.2.1.1.1 China Contrast Media Agent and Injector System Market (by Product)
          • 3.4.3.2.1.1.1.1 China Contrast Media Injector System Market (by Product)
        • 3.4.3.2.2 Japan
          • 3.4.3.2.2.1 Market Sizing and Forecast
          • 3.4.3.2.2.1.1 Japan Contrast Media Agent and Injector System Market (by Product)
          • 3.4.3.2.2.1.1.1 Japan Contrast Media Injector System Market (by Product)
        • 3.4.3.2.3 India
          • 3.4.3.2.3.1 Market Sizing and Forecast
          • 3.4.3.2.3.1.1 India Contrast Media Agent and Injector System Market (by Product)
          • 3.4.3.2.3.1.1.1 India Contrast Media Injector System Market (by Product)
        • 3.4.3.2.4 Australia
          • 3.4.3.2.4.1 Market Sizing and Forecast
          • 3.4.3.2.4.1.1 Australia Contrast Media Agent and Injector System Market (by Product)
          • 3.4.3.2.4.1.1.1 Australia Contrast Media Injector System Market (by Product)
        • 3.4.3.2.5 Rest-of-Asia-Pacific
          • 3.4.3.2.5.1 Market Sizing and Forecast
          • 3.4.3.2.5.1.1 Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
          • 3.4.3.2.5.1.1.1 Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)
  • 3.5 Rest-of-the-World
    • 3.5.1 Key Findings
    • 3.5.2 Market Dynamics
      • 3.5.2.1 Impact Analysis
    • 3.5.3 Market Size and Forecast
      • 3.5.3.1 Rest-of-the-World Contrast Media Agent and Injector System Market (by Product)
      • 3.5.3.2 Rest-of-the-World Contrast Media Injector System Market (by Product)

4 Markets - Competitive Benchmarking & Company Profiles

  • 4.1 Competitive Benchmarking
    • 4.1.1 Key Strategies and Development
      • 4.1.1.1 Regulatory and Legal Activities
      • 4.1.1.2 Partnerships, Collaborations, and Business Expansions
      • 4.1.1.3 Mergers and Acquisitions
      • 4.1.1.4 New Offerings
    • 4.1.2 Market Share Analysis
      • 4.1.2.1 Market Share Analysis, by Contrast Media Agent Market
      • 4.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
  • 4.2 Contrast Media Ecosystem Active Players
  • 4.3 Company Profiles
    • 4.3.1 Bayer AG
      • 4.3.1.1 Company Overview
      • 4.3.1.2 Role of Bayer AG in the Global Contrast Media Agent and Injector System Market
      • 4.3.1.3 Financials
      • 4.3.1.4 Recent Developments
      • 4.3.1.5 Analyst Perception
    • 4.3.2 Beijing Beilu Pharmaceutical Co. Ltd.
      • 4.3.2.1 Company Overview
      • 4.3.2.2 Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Global Contrast Media Agent and Injector System Market
      • 4.3.2.3 Recent Developments
      • 4.3.2.4 Analyst Perception
    • 4.3.3 Bracco Group
      • 4.3.3.1 Company Overview
      • 4.3.3.2 Role of Bracco Group in the Global Contrast Media Agent and Injector System Market
      • 4.3.3.3 Recent Developments
      • 4.3.3.4 Analyst Perception
    • 4.3.4 Fresenius SE & Co. KGaA
      • 4.3.4.1 Company Overview
      • 4.3.4.2 Role of Fresenius SE & Co. KGaA in the Global Contrast Media Agent and Injector System Market
      • 4.3.4.3 Financials
      • 4.3.4.4 Recent Developments
      • 4.3.4.5 Analyst Perception
    • 4.3.5 FUJIFILM Holdings Corporation
      • 4.3.5.1 Company Overview
      • 4.3.5.2 Role of FUJIFILM Holdings Corporation in the Global Contrast Media Agent and Injector System Market
      • 4.3.5.3 Financials
      • 4.3.5.4 Analyst Perception
    • 4.3.6 General Electric Company
      • 4.3.6.1 Company Overview
      • 4.3.6.2 Role of General Electric Company in the Global Contrast Media Agent and Injector System Market
      • 4.3.6.3 Financials
      • 4.3.6.4 Recent Developments
      • 4.3.6.5 Analyst Perspective
    • 4.3.7 Guerbet
      • 4.3.7.1 Company Overview
      • 4.3.7.2 Role of Guerbet in the Global Contrast Media Agent and Injector System Market
      • 4.3.7.3 Financials
      • 4.3.7.4 Recent Developments
      • 4.3.7.5 Analyst Perception
    • 4.3.8 Jiangsu Hengrui Pharmaceutical Co., Ltd.
      • 4.3.8.1 Company Overview
      • 4.3.8.2 Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Global Contrast Media Agent and Injector System Market
      • 4.3.8.3 Recent Developments
      • 4.3.8.4 Analyst Perception
    • 4.3.9 Jodas Expoim Pvt. Ltd.
      • 4.3.9.1 Company Overview
      • 4.3.9.2 Role of Jodas Expoim Pvt. Ltd. in the Global Contrast Media Agent and Injector System Market
      • 4.3.9.3 Analyst Perception
    • 4.3.10 Lantheus Holdings, Inc.
      • 4.3.10.1 Company Overview
      • 4.3.10.2 Role of Lantheus Holdings, Inc. in the Global Contrast Media Agent and Injector System Market
      • 4.3.10.3 Financials
      • 4.3.10.4 Recent Developments
      • 4.3.10.5 Analyst Perspective
    • 4.3.11 Shenzen Seacrown Electromechanical Co., Ltd.
      • 4.3.11.1 Company Overview
      • 4.3.11.2 Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Global Contrast Media Agent and Injector System Market
      • 4.3.11.3 Recent Developments
      • 4.3.11.4 Analyst Perception
    • 4.3.12 Sino Medical-Device Technology Co., Ltd.
      • 4.3.12.1 Company Overview
      • 4.3.12.2 Role of Sino Medical-Device Technology Co., Ltd. in the Global Contrast Media Agent and Injector System Market
      • 4.3.12.3 Analyst Perception
    • 4.3.13 ulrich GmbH & Co. KG
      • 4.3.13.1 Company Overview
      • 4.3.13.2 Role of ulrich GmbH & Co. KG in the Global Contrast Media Agent and Injector System Market
      • 4.3.13.3 Recent Developments
      • 4.3.13.4 Analyst Perception
    • 4.3.14 Unijules Life Sciences Ltd.
      • 4.3.14.1 Company Overview
      • 4.3.14.2 Role of Unijules Life Sciences Ltd. in the Global Contrast Media Agent and Injector System Market
      • 4.3.14.3 Analyst Perception